Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
  1. 4 Open-market sale Chief Scientific Officer sold 3,892 shares at $4.39 ($17,086)
  2. 4 Open-market sale Chief Operations Officer sold 3,892 shares at $4.39 ($17,086)
  3. 4 Open-market sale President and CEO sold 15,313 shares at $4.39 ($67,224)
  4. 4 Grant or award Chief Medical Officer acquired 13,750 shares (grant or award)
  5. 4 Grant or award Chief Scientific Officer acquired 13,750 shares (grant or award)
  6. 4 Grant or award Chief Operations Officer acquired 13,750 shares (grant or award)
  7. 4 Grant or award President and CEO acquired 37,500 shares (grant or award)
  8. 4 Grant or award Chief Medical Officer acquired 9,100 shares (grant or award)
  9. 4 Grant or award President and CEO acquired 27,200 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale President and CEO sold 4,523 shares at $4.51 ($20,399)
  13. 4 Open-market buy Director bought 9,000 shares at $4.00 ($36,000)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale President and CEO sold 4,806 shares at $4.38 ($21,041)
  18. 4 Open-market buy Chief Medical Officer bought 20,000 shares at $3.99 ($79,850)
  19. 4 Open-market buy Director bought 1,900,000 shares at an average $3.72 ($7,059,872)
  20. 4 Open-market buy Chief Medical Officer bought 17,500 shares at an average $3.37 ($58,898)

Page 10 of 21 · 410 filings